Experts are rapidly examining retatrutide, a promising medication created by Eli Lilly, as a potential breakthrough in physique loss . Different than many earlier approaches, retatrutide is a dual -action compound targeting both GLP-1 and GIP, substances that impact appetite and glucose balance. Pr